Author:
Ringelstein-Harlev Shimrit,Avivi Irit,Fanadka Mona,Horowitz Netanel A.,Katz Tami
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference38 articles.
1. Scarfo L, Ferreri AJ, Ghia P (2016) Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol 104:169–182
2. Jak M, Mous R, Remmerswaal EB, Spijker R, Jaspers A, Yague A, Eldering E, Van Lier RA, Van Oers MH (2009) Enhanced formation and survival of CD4 + CD25hi Foxp3 + T-cells in chronic lymphocytic leukemia. Leuk Lymphoma 50:788–801
3. Kiaii S, Choudhury A, Mozaffari F, Kimby E, Osterborg A, Mellstedt H (2005) Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease. Med Oncol 22:291–302
4. Ramsay AG, Johnson AJ, Lee AM, Gorgun G, Le Dieu R, Blum W, Byrd JC, Gribben JG (2008) Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest 118:2427–2437
5. Ramsay AG, Evans R, Kiaii S, Svensson L, Hogg N, Gribben JG (2013) Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide. Blood 121:2704–2714
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献